title: Bisphosphonate-related osteonecrosis of the jaw.
abstract: Although there has been a growing body of literature about bisphosphonates since 1969, it was not until 2003 that treatment with this medication was associated with osteonecrosis of the jaw. Presented herein is such a case.
authors.affiliation: Department of Pathlogy at Louisiana State University Health Sciences Center in Shreveport.
authors.forename: Camille
authors.initials: C
authors.lastname: Robichaux
authors.affiliation: Department of Pathlogy at Louisiana State University Health Sciences Center in Shreveport.
authors.forename: Menchu
authors.initials: M
authors.lastname: Ong
authors.affiliation: Department of Pathlogy at Louisiana State University Health Sciences Center in Shreveport.
authors.forename: Diana
authors.initials: D
authors.lastname: Veillon
authors.affiliation: Department of Pathlogy at Louisiana State University Health Sciences Center in Shreveport.
authors.forename: Stavan
authors.initials: S
authors.lastname: Patel
authors.affiliation: Department of Pathlogy at Louisiana State University Health Sciences Center in Shreveport.
authors.forename: James
authors.initials: J
authors.lastname: Cotelingam
mesh_terms: D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000473:pathology*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D004164:Diphosphonates